RSS

LAHO Lans Holdings, Inc.

Mod: SHEEPWOLF
Last Post: 08/19/21
Followers: 11
Posts Today: 0
Views Today: 20

LAHO Stock Quote & Tools

$0.0046 ▲ +0.0000 (+0.00%) As of Sep 6, 4:00 PM
Last0.0046
$ Chg0.0000
Open—
High—
Beta-5.3293
Year High0.005
Market Cap—
P/B Ratio—
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0046
Low—
VWAP0.00425
Year Low0.000
Total Shares—
Shares Out4.00B
Float4.00B
Exchange
Technology Software & IT Services

LAHO Stock Message Board Discussion

  1. dw
  2. 4 MY T

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 192

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 20

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Cookie Storage Solution Enhances Baking Experience

Updated Category News Views 311

Innovative Cookie Storage & Cooling Solution In the realm of baking, having the right tools can make all the difference, especially when it comes to cooling and storing cookies. An inventive individual from New Kent faced frustrations while trying to manage space during the festive baking period. Realizing the need for a solution, this inventor developed the SHERIS COOKIE...

Continue Reading
Alarum Technologies Securities Class Action Update and Analysis

Updated Category News Views 122

Understanding Alarum Technologies Securities Class Action Investors of Alarum Technologies Ltd. (NASDAQ: ALAR) may be facing a significant turning point regarding their investments. A class action lawsuit has been initiated concerning the actions of the company during a specified period. Those affected during this critical time frame have important rights and potential...

Continue Reading
TransCode Therapeutics Schedules Adjourned Special Meeting Updates

Updated Category News Views 211

TransCode Therapeutics Provides Updates on Adjourned Special Meeting TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has announced the adjournment of its Special Meeting, originally scheduled to gather shareholder votes on critical proposals. The meeting will now take place virtually on May 2, allowing shareholders to participate in a flexible and accessible format. The delay...

Continue Reading
Understanding Rep. Mike Kelly's Recent Union Pacific Stock Trading

Updated Category News Views 219

Understanding Rep. Mike Kelly's Recent Stock Activity Recently filed disclosures reveal that Representative Mike Kelly took part in a noteworthy transaction involving Union Pacific, valued between $15,001 and $50,000. This filing was made on December 12, 2024, highlighting the ongoing stock activities of congressional members. As of now, the share price for Union Pacific...

Continue Reading
Cohen & Steers Fund Details: Distribution and Returns Overview

Updated Category News Views 84

Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) stirred the pot back in 2024 when it laid out its managed distribution policy to bolster returns and maintain shareholder interest. The monthly distributions, set at a fixed rate per common share, aimed to give investors a reliable income stream while capitalizing on various investment opportunities throughout the...

Continue Reading